[go: up one dir, main page]

NZ225659A - Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives - Google Patents

Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives

Info

Publication number
NZ225659A
NZ225659A NZ225659A NZ22565988A NZ225659A NZ 225659 A NZ225659 A NZ 225659A NZ 225659 A NZ225659 A NZ 225659A NZ 22565988 A NZ22565988 A NZ 22565988A NZ 225659 A NZ225659 A NZ 225659A
Authority
NZ
New Zealand
Prior art keywords
naphthyridine
dihydro
oxo
fluoro
carboxylic acid
Prior art date
Application number
NZ225659A
Other languages
English (en)
Inventor
Prabhavathi Fernandes
Daniel Tim-Wo Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NZ225659A publication Critical patent/NZ225659A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ225659A 1987-08-04 1988-08-02 Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives NZ225659A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8141387A 1987-08-04 1987-08-04

Publications (1)

Publication Number Publication Date
NZ225659A true NZ225659A (en) 1991-10-25

Family

ID=22164001

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ225659A NZ225659A (en) 1987-08-04 1988-08-02 Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives

Country Status (10)

Country Link
EP (1) EP0302372B1 (xx)
JP (1) JP2655691B2 (xx)
KR (1) KR0133176B1 (xx)
AT (1) ATE83377T1 (xx)
AU (1) AU2037088A (xx)
CA (1) CA1314228C (xx)
DE (1) DE3876712T2 (xx)
DK (1) DK175609B1 (xx)
IE (1) IE62600B1 (xx)
NZ (1) NZ225659A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3910920A1 (de) * 1989-04-05 1990-10-11 Bayer Ag Enantiomerenreine 7-(3-amino-1-pyrrolidinyl)-chinolon- und -naphthyridoncarbonsaeuren
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
ES2095809B1 (es) * 1995-07-27 1997-12-16 Sint Quimica Sa Procedimiento para la preparacion de acidos naftiridin carboxilicos y sus sales.
US5739342A (en) * 1997-03-03 1998-04-14 Abbott Laboratories Process for the preparation of nicotinic acids
US6531594B2 (en) 2000-08-24 2003-03-11 Mitsubishi Chemical Corporation Process for producing 1H-3-aminopyrrolidine and derivatives thereof
JP2002284761A (ja) * 2001-01-17 2002-10-03 Toray Ind Inc 光学活性３−アミノピロリジン−２，５−ジオン誘導体および光学活性３−アミノピロリジン誘導体の製造方法
DE60127805T2 (de) * 2001-02-19 2007-12-27 Toray Fine Chemicals Co.Ltd., Urayasu Verfahren zur Herstellung von optisch aktiven 3-Aminopyrrolidin-2,5-dion-derivaten und optisch aktiven 3-Aminopyrrolidin-derivaten
US6348600B1 (en) 2001-02-20 2002-02-19 Toray Industries, Inc. Methods for making optically active 3-aminopyrrolidine-2,5-dione derivative and optically active 3-aminopyrrolidine derivative
GB201708606D0 (en) 2017-05-30 2017-07-12 King S College London Antibiotic resistance breakers
WO2023141689A1 (pt) 2022-01-28 2023-08-03 Universidade Federal De Minas Gerais - Ufmg Composições antimicrobianas de longa duração com ativos catiônicos e excipientes aniônicos e usos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
JPS6272616A (ja) * 1985-09-27 1987-04-03 Toyama Chem Co Ltd 抗菌剤
JPS61137819A (ja) * 1985-10-28 1986-06-25 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩を含有する抗菌剤
DE3542972A1 (de) * 1985-12-05 1987-06-11 Merck Patent Gmbh Pharmakadepot
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren

Also Published As

Publication number Publication date
CA1314228C (en) 1993-03-09
KR0133176B1 (ko) 1998-04-17
EP0302372B1 (en) 1992-12-16
KR890003378A (ko) 1989-04-14
ATE83377T1 (de) 1993-01-15
EP0302372A1 (en) 1989-02-08
IE882233L (en) 1989-02-04
JPH01110626A (ja) 1989-04-27
AU2037088A (en) 1989-03-02
DE3876712T2 (de) 1993-05-19
DE3876712D1 (de) 1993-01-28
DK435288A (da) 1989-02-05
IE62600B1 (en) 1995-02-22
JP2655691B2 (ja) 1997-09-24
DK435288D0 (da) 1988-08-04
DK175609B1 (da) 2004-12-27

Similar Documents

Publication Publication Date Title
IL88755A (en) (1:, 2, 3:)-3-substituted-2- hydroxycyclo- butanemethanol derivatives and pharmaceutical and veterinary compositions containing the same
DK0379979T3 (xx)
ATE37882T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
IL86381A0 (en) Oxetanocins and pharmaceutical compositions containing the same
AU591640B2 (en) Quinolonecarboxylic acid derivatives
NZ225659A (en) Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives
NZ229861A (en) 2,5,6-trisubstituted pyridine-3-carboxylic acids and acid derivatives
EP0288969A3 (en) Antiulcer composition
EP0188254A3 (en) New cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them
NZ228216A (en) Tetrahydroimidazo(4,5,1-jk)(1,4)benzodiazepinone derivatives and antiviral compositions
IE852823L (en) Medicaments containing spergualin
MY108303A (en) Neuroleptic 2-substituted perhydro-1-h-pyrido [1,2-a]pyrazines.
IL87221A (en) 7-(2-methyl- 4-aminopyrrolidinyl) naphthyridine or quinoline compounds and pharmaceutical compositions containing them
HUT41773A (en) Process for producing 2-/ 4-substituted-amino-3-oxo-2-isoxazolidinyl-5-oxo-2-tetrahydrofurane-carboxylic acid derivatives and pharmaceutical compositions containing them
IL78780A (en) 1,3-oxathiane-4-phenyl-5-alkenyl derivatives,their preparation and pharmaceutical compositions containing them
DK36788D0 (da) 6beta-(heterocyclyl-(s)-hydroxy)methyl-penicillansyreforbindelser og farmaceutiske praeparater indeholdende disse
IL106934A0 (en) Heteroarenylpiperazines,a process for their preparation and their use as medicaments
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.
EP0177728A3 (en) Arphamenine derivatives, a process for their preparation and their use as medicament